Keyphrases
All Cancer
14%
Cancer Cells
100%
Cell-less
14%
Constitutive Activation
14%
Dual Treatment
14%
ERK Pathway
100%
Extracellular Regulated Protein Kinases
14%
Human Cancer
14%
In Cancer
100%
Infected Cells
14%
Interferon Response
100%
Interferon System
14%
Interferon Treatment
14%
Interferon-α (IFN-α)
85%
Malignant Cells
28%
MEK Inhibitor (MEKi)
14%
MEK-ERK Pathway
28%
Mitogen-activated Protein Kinase
14%
MxA Protein
14%
NIH3T3
14%
Oncolysis
100%
Oncolytic Virus
14%
Overexpressing
14%
Pregenomic RNA (pgRNA)
14%
Primary Cells
14%
RAF1
100%
RNA Synthesis
14%
Selective Replication
14%
Stably Expressing
14%
U0126
57%
Vesicular Stomatitis Virus
100%
Virus Infection
14%
Virus RNA
14%
Medicine and Dentistry
Cancer
22%
Cancer Cell
100%
Cell Line
11%
Cell Signaling Pathway
100%
Interferon
100%
Malignant Neoplasm
11%
MEK Inhibitor
11%
Mitogen Activated Protein Kinase Kinase
11%
Myxovirus Resistance Protein A
11%
Oncolytic Virus
11%
Protein Kinases
11%
RNA Synthesis
11%
U0126
44%
Upregulation
11%
Vesiculovirus
100%
Virus Infection
11%
Virus RNA
22%
Pharmacology, Toxicology and Pharmaceutical Science
1,4 Diamino 1,4 Bis(2 Aminophenylthio) 2,3 Dicyanobutadiene
44%
Interferon
100%
Malignant Neoplasm
100%
Mitogen Activated Protein Kinase Kinase
11%
Mitogen Activated Protein Kinase Kinase Inhibitor
11%
Myxovirus Resistance Protein A
11%
Oncolytic Virus
11%
Protein Kinases
11%
Vesiculovirus
100%
Virus Infection
11%
Virus RNA
22%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Interferon
100%
MEK Inhibitor
11%
Mitogen-Activated Protein Kinase Kinase
11%
Primary Cell
11%
Protein Kinases
11%
RNA
11%
RNA Synthesis
11%
RNA Virus
11%
U0126
44%
Upregulation
11%
Vesiculovirus
100%
Immunology and Microbiology
Cancer Cell
100%
Cell Line
11%
interferon
100%
Mitogen
11%
Oncolytic Virus
11%
RNA Synthesis
11%
RNA Virus
11%
Upregulation
11%
Vesiculovirus
100%
Viral Disease
11%